

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.94759060 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.94759060 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.87679794 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.87679794 |
| 5 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.30931163 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 6.25898867 |
| 7 | sulfur amino acid catabolic process (GO:0000098) | 6.17336008 |
| 8 | glyoxylate metabolic process (GO:0046487) | 5.72304271 |
| 9 | tryptophan catabolic process (GO:0006569) | 5.70380162 |
| 10 | indole-containing compound catabolic process (GO:0042436) | 5.70380162 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 5.70380162 |
| 12 | kynurenine metabolic process (GO:0070189) | 5.60311148 |
| 13 | bile acid biosynthetic process (GO:0006699) | 5.41656968 |
| 14 | high-density lipoprotein particle remodeling (GO:0034375) | 5.39367227 |
| 15 | cysteine metabolic process (GO:0006534) | 5.32694721 |
| 16 | tryptophan metabolic process (GO:0006568) | 5.32019648 |
| 17 | urea cycle (GO:0000050) | 5.26252463 |
| 18 | urea metabolic process (GO:0019627) | 5.26252463 |
| 19 | alpha-linolenic acid metabolic process (GO:0036109) | 5.23337965 |
| 20 | serine family amino acid catabolic process (GO:0009071) | 5.07972714 |
| 21 | negative regulation of fibrinolysis (GO:0051918) | 5.01562898 |
| 22 | regulation of cholesterol esterification (GO:0010872) | 4.93978227 |
| 23 | nitrogen cycle metabolic process (GO:0071941) | 4.87517920 |
| 24 | bile acid metabolic process (GO:0008206) | 4.86021660 |
| 25 | reverse cholesterol transport (GO:0043691) | 4.84499557 |
| 26 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.82319769 |
| 27 | protein carboxylation (GO:0018214) | 4.82319769 |
| 28 | regulation of fibrinolysis (GO:0051917) | 4.80954367 |
| 29 | regulation of triglyceride catabolic process (GO:0010896) | 4.77204272 |
| 30 | regulation of protein activation cascade (GO:2000257) | 4.74852385 |
| 31 | acylglycerol homeostasis (GO:0055090) | 4.71797706 |
| 32 | triglyceride homeostasis (GO:0070328) | 4.71797706 |
| 33 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.68386682 |
| 34 | phospholipid efflux (GO:0033700) | 4.67422892 |
| 35 | complement activation, alternative pathway (GO:0006957) | 4.65723309 |
| 36 | homocysteine metabolic process (GO:0050667) | 4.64143907 |
| 37 | plasma lipoprotein particle remodeling (GO:0034369) | 4.63003875 |
| 38 | protein-lipid complex remodeling (GO:0034368) | 4.63003875 |
| 39 | macromolecular complex remodeling (GO:0034367) | 4.63003875 |
| 40 | negative regulation of cholesterol transport (GO:0032375) | 4.62110589 |
| 41 | negative regulation of sterol transport (GO:0032372) | 4.62110589 |
| 42 | aromatic amino acid family metabolic process (GO:0009072) | 4.57321870 |
| 43 | amino-acid betaine metabolic process (GO:0006577) | 4.55671606 |
| 44 | lysine metabolic process (GO:0006553) | 4.46036681 |
| 45 | lysine catabolic process (GO:0006554) | 4.46036681 |
| 46 | alpha-amino acid catabolic process (GO:1901606) | 4.43113975 |
| 47 | regulation of complement activation (GO:0030449) | 4.42111897 |
| 48 | bile acid and bile salt transport (GO:0015721) | 4.37977118 |
| 49 | plasma lipoprotein particle assembly (GO:0034377) | 4.35685616 |
| 50 | cellular ketone body metabolic process (GO:0046950) | 4.35227409 |
| 51 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.33981524 |
| 52 | cholesterol efflux (GO:0033344) | 4.32738435 |
| 53 | glycine metabolic process (GO:0006544) | 4.23178789 |
| 54 | cellular glucuronidation (GO:0052695) | 4.22249900 |
| 55 | tyrosine metabolic process (GO:0006570) | 4.20822640 |
| 56 | cellular amino acid catabolic process (GO:0009063) | 4.19994637 |
| 57 | response to peptidoglycan (GO:0032494) | 4.17767845 |
| 58 | intestinal cholesterol absorption (GO:0030299) | 4.17467089 |
| 59 | plasma lipoprotein particle clearance (GO:0034381) | 4.15608568 |
| 60 | serine family amino acid metabolic process (GO:0009069) | 4.12608136 |
| 61 | regulation of cholesterol homeostasis (GO:2000188) | 4.12529024 |
| 62 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.07966771 |
| 63 | imidazole-containing compound metabolic process (GO:0052803) | 4.03802294 |
| 64 | ethanol oxidation (GO:0006069) | 4.03727920 |
| 65 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.03696457 |
| 66 | GDP-mannose metabolic process (GO:0019673) | 4.00829498 |
| 67 | detection of bacterium (GO:0016045) | 3.99979293 |
| 68 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.99110996 |
| 69 | glutamate metabolic process (GO:0006536) | 3.99104366 |
| 70 | cellular modified amino acid catabolic process (GO:0042219) | 3.98515519 |
| 71 | drug catabolic process (GO:0042737) | 3.98023626 |
| 72 | indolalkylamine metabolic process (GO:0006586) | 3.93953593 |
| 73 | amine catabolic process (GO:0009310) | 3.93699860 |
| 74 | cellular biogenic amine catabolic process (GO:0042402) | 3.93699860 |
| 75 | serine family amino acid biosynthetic process (GO:0009070) | 3.93496296 |
| 76 | coenzyme catabolic process (GO:0009109) | 3.92029805 |
| 77 | low-density lipoprotein particle remodeling (GO:0034374) | 3.89510797 |
| 78 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.88159337 |
| 79 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.88159337 |
| 80 | cholesterol homeostasis (GO:0042632) | 3.86703492 |
| 81 | regulation of bile acid biosynthetic process (GO:0070857) | 3.86272052 |
| 82 | protein-lipid complex assembly (GO:0065005) | 3.86155408 |
| 83 | benzene-containing compound metabolic process (GO:0042537) | 3.85801185 |
| 84 | detection of other organism (GO:0098543) | 3.82627257 |
| 85 | flavonoid metabolic process (GO:0009812) | 3.81238882 |
| 86 | heme transport (GO:0015886) | 3.79825217 |
| 87 | sterol homeostasis (GO:0055092) | 3.79611222 |
| 88 | arginine metabolic process (GO:0006525) | 3.77615903 |
| 89 | proline metabolic process (GO:0006560) | 3.77305103 |
| 90 | immunoglobulin mediated immune response (GO:0016064) | 3.74617870 |
| 91 | ketone body metabolic process (GO:1902224) | 3.74139937 |
| 92 | organic acid catabolic process (GO:0016054) | 3.72845274 |
| 93 | carboxylic acid catabolic process (GO:0046395) | 3.72845274 |
| 94 | plasma lipoprotein particle organization (GO:0071827) | 3.72806194 |
| 95 | uronic acid metabolic process (GO:0006063) | 3.72483233 |
| 96 | glucuronate metabolic process (GO:0019585) | 3.72483233 |
| 97 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.72065843 |
| 98 | acetyl-CoA metabolic process (GO:0006084) | 3.69984266 |
| 99 | short-chain fatty acid metabolic process (GO:0046459) | 3.68040728 |
| 100 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.66886120 |
| 101 | phospholipid homeostasis (GO:0055091) | 3.63277917 |
| 102 | cytolysis (GO:0019835) | 3.58737411 |
| 103 | fatty acid beta-oxidation (GO:0006635) | 3.58283170 |
| 104 | fibrinolysis (GO:0042730) | 3.58219152 |
| 105 | lipoprotein metabolic process (GO:0042157) | 3.58167850 |
| 106 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.57503483 |
| 107 | response to nitrosative stress (GO:0051409) | 3.57008506 |
| 108 | positive regulation of lipid catabolic process (GO:0050996) | 3.56746003 |
| 109 | neutrophil activation involved in immune response (GO:0002283) | 3.47467058 |
| 110 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.44503607 |
| 111 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.30913749 |
| 112 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.22457934 |
| 113 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.22457934 |
| 114 | modulation by symbiont of host immune response (GO:0052553) | 3.22457934 |
| 115 | positive regulation by symbiont of host defense response (GO:0052509) | 3.22457934 |
| 116 | modulation by symbiont of host defense response (GO:0052031) | 3.22457934 |
| 117 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.22457934 |
| 118 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.21587416 |
| 119 | mannose metabolic process (GO:0006013) | 3.21496969 |
| 120 | angiotensin maturation (GO:0002003) | 3.08875539 |
| 121 | NADH metabolic process (GO:0006734) | 3.08516480 |
| 122 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.02990112 |
| 123 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.93000543 |
| 124 | detection of external biotic stimulus (GO:0098581) | 2.91222920 |
| 125 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.84865060 |
| 126 | pinocytosis (GO:0006907) | 2.83034063 |
| 127 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.80665950 |
| 128 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.78389738 |
| 129 | response to muramyl dipeptide (GO:0032495) | 2.77208760 |
| 130 | positive thymic T cell selection (GO:0045059) | 2.76283340 |
| 131 | regulation of mast cell degranulation (GO:0043304) | 2.76264672 |
| 132 | positive regulation of antigen processing and presentation (GO:0002579) | 2.74668070 |
| 133 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.73903751 |
| 134 | glycosphingolipid catabolic process (GO:0046479) | 2.73302995 |
| 135 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.70905504 |
| 136 | negative regulation of cell killing (GO:0031342) | 2.70905504 |
| 137 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.70572816 |
| 138 | macrophage activation involved in immune response (GO:0002281) | 2.69171615 |
| 139 | regulation of leukocyte degranulation (GO:0043300) | 2.67504368 |
| 140 | positive regulation of B cell differentiation (GO:0045579) | 2.67250546 |
| 141 | B cell mediated immunity (GO:0019724) | 2.65734720 |
| 142 | regulation of cellular extravasation (GO:0002691) | 2.64084624 |
| 143 | NIK/NF-kappaB signaling (GO:0038061) | 2.64064189 |
| 144 | detection of biotic stimulus (GO:0009595) | 2.60736817 |
| 145 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.59590641 |
| 146 | pentose-phosphate shunt (GO:0006098) | 2.58831672 |
| 147 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.57787946 |
| 148 | regulation of necrotic cell death (GO:0010939) | 2.57380122 |
| 149 | pentose metabolic process (GO:0019321) | 2.57035527 |
| 150 | mature B cell differentiation involved in immune response (GO:0002313) | 2.54419487 |
| 151 | glycolipid catabolic process (GO:0019377) | 2.52605832 |
| 152 | regulation of antigen processing and presentation (GO:0002577) | 2.51597168 |
| 153 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.50843178 |
| 154 | regulation of gamma-delta T cell activation (GO:0046643) | 2.48903473 |
| 155 | UV protection (GO:0009650) | 2.46969442 |
| 156 | negative regulation of B cell apoptotic process (GO:0002903) | 2.44259265 |
| 157 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.42786807 |
| 158 | response to host immune response (GO:0052572) | 2.42780459 |
| 159 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.42780459 |
| 160 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.42260424 |
| 161 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.42136143 |
| 162 | amyloid precursor protein catabolic process (GO:0042987) | 2.41042304 |
| 163 | negative regulation of granulocyte differentiation (GO:0030853) | 2.38830347 |
| 164 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.37834001 |
| 165 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.37167618 |
| 166 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.35777642 |
| 167 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.34454882 |
| 168 | glucose catabolic process (GO:0006007) | 2.34195954 |
| 169 | negative regulation of innate immune response (GO:0045824) | 2.33866858 |
| 170 | response to host (GO:0075136) | 2.33830690 |
| 171 | response to host defenses (GO:0052200) | 2.33830690 |
| 172 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.33830690 |
| 173 | regulation of superoxide anion generation (GO:0032928) | 2.33769471 |
| 174 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.32702457 |
| 175 | negative regulation of interleukin-8 production (GO:0032717) | 2.31676159 |
| 176 | defense response to protozoan (GO:0042832) | 2.30488224 |
| 177 | proline biosynthetic process (GO:0006561) | 2.30439093 |
| 178 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.29920898 |
| 179 | peptide catabolic process (GO:0043171) | 2.27682990 |
| 180 | response to interferon-beta (GO:0035456) | 2.27409090 |
| 181 | response to type I interferon (GO:0034340) | 2.27226074 |
| 182 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.26329440 |
| 183 | type I interferon signaling pathway (GO:0060337) | 2.26193729 |
| 184 | cellular response to type I interferon (GO:0071357) | 2.26193729 |
| 185 | epoxygenase P450 pathway (GO:0019373) | 2.24321942 |
| 186 | pyrimidine-containing compound salvage (GO:0008655) | 2.23555080 |
| 187 | pyrimidine nucleoside salvage (GO:0043097) | 2.23555080 |
| 188 | protein kinase C signaling (GO:0070528) | 2.23337766 |
| 189 | response to protozoan (GO:0001562) | 2.22949663 |
| 190 | respiratory burst (GO:0045730) | 2.22187149 |
| 191 | negative regulation of interleukin-12 production (GO:0032695) | 2.21569178 |
| 192 | glutathione biosynthetic process (GO:0006750) | 2.20425319 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.74214956 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.77267137 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.97613037 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.89443535 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.91415275 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.88828793 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.62093305 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.63216920 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.59826894 |
| 10 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.45178972 |
| 11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.52596435 |
| 12 | MYC_22102868_ChIP-Seq_BL_Human | 2.34213823 |
| 13 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.23664605 |
| 14 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.23010617 |
| 15 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.19692226 |
| 16 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.05378352 |
| 17 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.6049768 |
| 18 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.99674339 |
| 19 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.97199135 |
| 20 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.95902923 |
| 21 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.87845878 |
| 22 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.76410062 |
| 23 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.75452734 |
| 24 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72048923 |
| 25 | MAF_26560356_Chip-Seq_TH1_Human | 1.71888482 |
| 26 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.70064317 |
| 27 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.65513385 |
| 28 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.62206213 |
| 29 | UTX_26944678_Chip-Seq_JUKART_Human | 1.62176678 |
| 30 | MAF_26560356_Chip-Seq_TH2_Human | 1.60891476 |
| 31 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.59718858 |
| 32 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.58958811 |
| 33 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.58371925 |
| 34 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.58149404 |
| 35 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.56874122 |
| 36 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.55001800 |
| 37 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.51756663 |
| 38 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.46282775 |
| 39 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.46076050 |
| 40 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.45687760 |
| 41 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.44504658 |
| 42 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.42799160 |
| 43 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.42440636 |
| 44 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.35444376 |
| 45 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.35213768 |
| 46 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.33599355 |
| 47 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.33540196 |
| 48 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.32998530 |
| 49 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.32104916 |
| 50 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.31090271 |
| 51 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.29627610 |
| 52 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.29406281 |
| 53 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.29246439 |
| 54 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.28992096 |
| 55 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.27394944 |
| 56 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.26101090 |
| 57 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.25213713 |
| 58 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.24876412 |
| 59 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.24535775 |
| 60 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.24239987 |
| 61 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.23441838 |
| 62 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22997537 |
| 63 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22218772 |
| 64 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.21250076 |
| 65 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.21066695 |
| 66 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20767776 |
| 67 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.19641792 |
| 68 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.19203824 |
| 69 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.16995274 |
| 70 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.15225084 |
| 71 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.14607822 |
| 72 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14467030 |
| 73 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.14426580 |
| 74 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.14389231 |
| 75 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13386367 |
| 76 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.11978242 |
| 77 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.11397866 |
| 78 | SPI1_23127762_ChIP-Seq_K562_Human | 1.10983215 |
| 79 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.10635255 |
| 80 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09582859 |
| 81 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09495459 |
| 82 | ATF3_27146783_Chip-Seq_COLON_Human | 1.08997887 |
| 83 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.08517478 |
| 84 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07352008 |
| 85 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.07149740 |
| 86 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.06827613 |
| 87 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.06120367 |
| 88 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.03382933 |
| 89 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.03214343 |
| 90 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.02936729 |
| 91 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.02666961 |
| 92 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.98034973 |
| 93 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.97785273 |
| 94 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.97334404 |
| 95 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.97314804 |
| 96 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.96050493 |
| 97 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.95322145 |
| 98 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.94765304 |
| 99 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.93437216 |
| 100 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.92358422 |
| 101 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.90892609 |
| 102 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.87974248 |
| 103 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.83832581 |
| 104 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.83337279 |
| 105 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.82145239 |
| 106 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.81858004 |
| 107 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.81853254 |
| 108 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.81147280 |
| 109 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.80910243 |
| 110 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.80296118 |
| 111 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.80259145 |
| 112 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.80208981 |
| 113 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.79355256 |
| 114 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.78177061 |
| 115 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.77799862 |
| 116 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.77444371 |
| 117 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.77344823 |
| 118 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.76973457 |
| 119 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.74128941 |
| 120 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.73343068 |
| 121 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.70271930 |
| 122 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.69470021 |
| 123 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.68639519 |
| 124 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.68414490 |
| 125 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.67305975 |
| 126 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.66937642 |
| 127 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.66718787 |
| 128 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.64659676 |
| 129 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.64376546 |
| 130 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.64275163 |
| 131 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.63503137 |
| 132 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.62933039 |
| 133 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.61562000 |
| 134 | GATA1_22025678_ChIP-Seq_K562_Human | 0.60543723 |
| 135 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.60477965 |
| 136 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.60277307 |
| 137 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.58995775 |
| 138 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.58628342 |
| 139 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.58087599 |
| 140 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.57852476 |
| 141 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.57467425 |
| 142 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.57004372 |
| 143 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.57004372 |
| 144 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.57004372 |
| 145 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.56542836 |
| 146 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.56175049 |
| 147 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.55502734 |
| 148 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.55362143 |
| 149 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.55144663 |
| 150 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.54091196 |
| 151 | P68_20966046_ChIP-Seq_HELA_Human | 0.54052214 |
| 152 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.53672620 |
| 153 | P300_27268052_Chip-Seq_Bcells_Human | 0.53086273 |
| 154 | GATA1_19941826_ChIP-Seq_K562_Human | 0.52608129 |
| 155 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.52587495 |
| 156 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.52397379 |
| 157 | SA1_27219007_Chip-Seq_Bcells_Human | 0.52181326 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.71100569 |
| 2 | MP0005360_urolithiasis | 7.46194786 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.37786662 |
| 4 | MP0005365_abnormal_bile_salt | 6.09443743 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.91219897 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.34036038 |
| 7 | MP0003252_abnormal_bile_duct | 3.68081487 |
| 8 | MP0009840_abnormal_foam_cell | 3.46656148 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.44697601 |
| 10 | MP0001666_abnormal_nutrient_absorption | 2.95631441 |
| 11 | MP0003436_decreased_susceptibility_to | 2.86582286 |
| 12 | MP0005332_abnormal_amino_acid | 2.78653597 |
| 13 | MP0005083_abnormal_biliary_tract | 2.77096142 |
| 14 | MP0003303_peritoneal_inflammation | 2.49868460 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.46300431 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.44556043 |
| 17 | MP0003195_calcinosis | 2.33959221 |
| 18 | MP0001835_abnormal_antigen_presentation | 2.26787736 |
| 19 | MP0005025_abnormal_response_to | 2.17618612 |
| 20 | MP0000609_abnormal_liver_physiology | 2.10715341 |
| 21 | MP0002118_abnormal_lipid_homeostasis | 2.05650833 |
| 22 | MP0003724_increased_susceptibility_to | 2.04625570 |
| 23 | MP0009278_abnormal_bone_marrow | 2.03941714 |
| 24 | MP0002419_abnormal_innate_immunity | 2.03835349 |
| 25 | MP0009333_abnormal_splenocyte_physiolog | 1.91106610 |
| 26 | MP0009785_altered_susceptibility_to | 1.84964084 |
| 27 | MP0002148_abnormal_hypersensitivity_rea | 1.83702437 |
| 28 | MP0005319_abnormal_enzyme/_coenzyme | 1.80197396 |
| 29 | MP0008260_abnormal_autophagy | 1.74668734 |
| 30 | MP0002138_abnormal_hepatobiliary_system | 1.74437888 |
| 31 | MP0005000_abnormal_immune_tolerance | 1.69752612 |
| 32 | MP0002396_abnormal_hematopoietic_system | 1.68349462 |
| 33 | MP0004947_skin_inflammation | 1.66218162 |
| 34 | MP0003172_abnormal_lysosome_physiology | 1.64965480 |
| 35 | MP0005397_hematopoietic_system_phenotyp | 1.64424751 |
| 36 | MP0001545_abnormal_hematopoietic_system | 1.64424751 |
| 37 | MP0001764_abnormal_homeostasis | 1.62641539 |
| 38 | MP0001800_abnormal_humoral_immune | 1.59762567 |
| 39 | MP0003868_abnormal_feces_composition | 1.59664079 |
| 40 | MP0002452_abnormal_antigen_presenting | 1.57542426 |
| 41 | MP0001819_abnormal_immune_cell | 1.57114184 |
| 42 | MP0002723_abnormal_immune_serum | 1.56851077 |
| 43 | MP0002420_abnormal_adaptive_immunity | 1.56279333 |
| 44 | MP0005387_immune_system_phenotype | 1.54618321 |
| 45 | MP0001790_abnormal_immune_system | 1.54618321 |
| 46 | MP0003763_abnormal_thymus_physiology | 1.53873479 |
| 47 | MP0000858_altered_metastatic_potential | 1.52319029 |
| 48 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.46503864 |
| 49 | MP0000465_gastrointestinal_hemorrhage | 1.45979648 |
| 50 | MP0003183_abnormal_peptide_metabolism | 1.45625012 |
| 51 | MP0002254_reproductive_system_inflammat | 1.44269351 |
| 52 | MP0000490_abnormal_crypts_of | 1.43622421 |
| 53 | MP0001845_abnormal_inflammatory_respons | 1.38021056 |
| 54 | MP0003866_abnormal_defecation | 1.37116850 |
| 55 | MP0003656_abnormal_erythrocyte_physiolo | 1.36313740 |
| 56 | MP0003705_abnormal_hypodermis_morpholog | 1.35753321 |
| 57 | MP0009643_abnormal_urine_homeostasis | 1.33896024 |
| 58 | MP0003186_abnormal_redox_activity | 1.32109422 |
| 59 | MP0000678_abnormal_parathyroid_gland | 1.32003099 |
| 60 | MP0005451_abnormal_body_composition | 1.30851566 |
| 61 | MP0001533_abnormal_skeleton_physiology | 1.30293622 |
| 62 | MP0003300_gastrointestinal_ulcer | 1.27824032 |
| 63 | MP0005671_abnormal_response_to | 1.24782806 |
| 64 | MP0002398_abnormal_bone_marrow | 1.24162558 |
| 65 | MP0000716_abnormal_immune_system | 1.21951300 |
| 66 | MP0004185_abnormal_adipocyte_glucose | 1.18071022 |
| 67 | MP0004858_abnormal_nervous_system | 1.17839144 |
| 68 | MP0000598_abnormal_liver_morphology | 1.14719034 |
| 69 | MP0005647_abnormal_sex_gland | 1.13980386 |
| 70 | MP0002429_abnormal_blood_cell | 1.13543748 |
| 71 | MP0009697_abnormal_copulation | 1.11887030 |
| 72 | MP0002722_abnormal_immune_system | 1.09353047 |
| 73 | MP0003011_delayed_dark_adaptation | 1.08525816 |
| 74 | MP0005076_abnormal_cell_differentiation | 1.07108923 |
| 75 | MP0002405_respiratory_system_inflammati | 1.04549290 |
| 76 | MP0000689_abnormal_spleen_morphology | 1.02091036 |
| 77 | MP0001849_ear_inflammation | 0.98731763 |
| 78 | MP0001663_abnormal_digestive_system | 0.95650677 |
| 79 | MP0009931_abnormal_skin_appearance | 0.93881264 |
| 80 | MP0009379_abnormal_foot_pigmentation | 0.92287011 |
| 81 | MP0002796_impaired_skin_barrier | 0.91840126 |
| 82 | MP0005409_darkened_coat_color | 0.91805854 |
| 83 | MP0005375_adipose_tissue_phenotype | 0.91440078 |
| 84 | MP0009053_abnormal_anal_canal | 0.90134764 |
| 85 | MP0005266_abnormal_metabolism | 0.88932928 |
| 86 | MP0005636_abnormal_mineral_homeostasis | 0.88542896 |
| 87 | MP0009764_decreased_sensitivity_to | 0.87703154 |
| 88 | MP0005376_homeostasis/metabolism_phenot | 0.87027699 |
| 89 | MP0002998_abnormal_bone_remodeling | 0.86568052 |
| 90 | MP0006036_abnormal_mitochondrial_physio | 0.84554054 |
| 91 | MP0001216_abnormal_epidermal_layer | 0.84412148 |
| 92 | MP0009642_abnormal_blood_homeostasis | 0.83438958 |
| 93 | MP0000604_amyloidosis | 0.83198659 |
| 94 | MP0009763_increased_sensitivity_to | 0.82988721 |
| 95 | MP0004381_abnormal_hair_follicle | 0.82820998 |
| 96 | MP0001664_abnormal_digestion | 0.80922982 |
| 97 | MP0008004_abnormal_stomach_pH | 0.80469144 |
| 98 | MP0001851_eye_inflammation | 0.79162113 |
| 99 | MP0008469_abnormal_protein_level | 0.78552231 |
| 100 | MP0002971_abnormal_brown_adipose | 0.77412256 |
| 101 | MP0005670_abnormal_white_adipose | 0.74922280 |
| 102 | MP0010234_abnormal_vibrissa_follicle | 0.74602200 |
| 103 | MP0005220_abnormal_exocrine_pancreas | 0.72834246 |
| 104 | MP0004264_abnormal_extraembryonic_tissu | 0.72211282 |
| 105 | MP0003453_abnormal_keratinocyte_physiol | 0.70441514 |
| 106 | MP0004130_abnormal_muscle_cell | 0.70153299 |
| 107 | MP0010368_abnormal_lymphatic_system | 0.69568057 |
| 108 | MP0002078_abnormal_glucose_homeostasis | 0.67277780 |
| 109 | MP0003638_abnormal_response/metabolism_ | 0.66715883 |
| 110 | MP0000639_abnormal_adrenal_gland | 0.65984468 |
| 111 | MP0000579_abnormal_nail_morphology | 0.65227008 |
| 112 | MP0005334_abnormal_fat_pad | 0.64584710 |
| 113 | MP0005084_abnormal_gallbladder_morpholo | 0.63431986 |
| 114 | MP0005448_abnormal_energy_balance | 0.59103307 |
| 115 | MP0005058_abnormal_lysosome_morphology | 0.58757503 |
| 116 | MP0009765_abnormal_xenobiotic_induced | 0.58659120 |
| 117 | MP0002060_abnormal_skin_morphology | 0.58157564 |
| 118 | MP0003075_altered_response_to | 0.55891582 |
| 119 | MP0003718_maternal_effect | 0.55699253 |
| 120 | MP0001756_abnormal_urination | 0.55205203 |
| 121 | MP0005464_abnormal_platelet_physiology | 0.54654458 |
| 122 | MP0002132_abnormal_respiratory_system | 0.54510186 |
| 123 | MP0002136_abnormal_kidney_physiology | 0.52372984 |
| 124 | MP0002876_abnormal_thyroid_physiology | 0.50732197 |
| 125 | MP0009115_abnormal_fat_cell | 0.48910706 |
| 126 | MP0005395_other_phenotype | 0.48664955 |
| 127 | MP0005666_abnormal_adipose_tissue | 0.47900375 |
| 128 | MP0003283_abnormal_digestive_organ | 0.47723055 |
| 129 | MP0005408_hypopigmentation | 0.47068732 |
| 130 | MP0005535_abnormal_body_temperature | 0.45068965 |
| 131 | MP0002249_abnormal_larynx_morphology | 0.42287060 |
| 132 | MP0003690_abnormal_glial_cell | 0.42154371 |
| 133 | MP0008873_increased_physiological_sensi | 0.41957982 |
| 134 | MP0001853_heart_inflammation | 0.41734126 |
| 135 | MP0000462_abnormal_digestive_system | 0.41418318 |
| 136 | MP0005501_abnormal_skin_physiology | 0.41395518 |
| 137 | MP0006035_abnormal_mitochondrial_morpho | 0.41065434 |
| 138 | MP0003953_abnormal_hormone_level | 0.40826910 |
| 139 | MP0006082_CNS_inflammation | 0.40393568 |
| 140 | MP0008872_abnormal_physiological_respon | 0.40191415 |
| 141 | MP0004782_abnormal_surfactant_physiolog | 0.39833970 |
| 142 | MP0003329_amyloid_beta_deposits | 0.39484868 |
| 143 | MP0008874_decreased_physiological_sensi | 0.39334035 |
| 144 | MP0001661_extended_life_span | 0.38754754 |
| 145 | MP0010030_abnormal_orbit_morphology | 0.38294758 |
| 146 | MP0005248_abnormal_Harderian_gland | 0.36923877 |
| 147 | MP0005023_abnormal_wound_healing | 0.35636433 |
| 148 | MP0002970_abnormal_white_adipose | 0.34969222 |
| 149 | MP0005166_decreased_susceptibility_to | 0.34500075 |
| 150 | MP0000467_abnormal_esophagus_morphology | 0.34406813 |
| 151 | MP0010155_abnormal_intestine_physiology | 0.34041460 |
| 152 | MP0000685_abnormal_immune_system | 0.32123412 |
| 153 | MP0000477_abnormal_intestine_morphology | 0.31936050 |
| 154 | MP0001873_stomach_inflammation | 0.31302302 |
| 155 | MP0002269_muscular_atrophy | 0.31211935 |
| 156 | MP0002822_catalepsy | 0.30077554 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.05328152 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.97122719 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.54964962 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.43921603 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 6.36430453 |
| 6 | Xanthomatosis (HP:0000991) | 6.02520404 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 5.79805299 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.12337782 |
| 9 | Hypolipoproteinemia (HP:0010981) | 4.74900065 |
| 10 | Hyperammonemia (HP:0001987) | 4.70209371 |
| 11 | Complement deficiency (HP:0004431) | 4.61150260 |
| 12 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.46578078 |
| 13 | Hyperglycinuria (HP:0003108) | 4.42040855 |
| 14 | Hyperglycinemia (HP:0002154) | 4.35979047 |
| 15 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.26906972 |
| 16 | Ketosis (HP:0001946) | 4.24902898 |
| 17 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.19941572 |
| 18 | Joint hemorrhage (HP:0005261) | 4.17880680 |
| 19 | Fat malabsorption (HP:0002630) | 4.10500668 |
| 20 | Abnormality of glycine metabolism (HP:0010895) | 4.10318302 |
| 21 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.10318302 |
| 22 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.06588319 |
| 23 | Hypoalphalipoproteinemia (HP:0003233) | 4.06227563 |
| 24 | Epidermoid cyst (HP:0200040) | 4.05575990 |
| 25 | Eczematoid dermatitis (HP:0000976) | 4.04933239 |
| 26 | Abnormality of methionine metabolism (HP:0010901) | 3.95852862 |
| 27 | Abnormality of the common coagulation pathway (HP:0010990) | 3.85367754 |
| 28 | Hypoglycemic coma (HP:0001325) | 3.81883722 |
| 29 | Recurrent abscess formation (HP:0002722) | 3.66473276 |
| 30 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.62595387 |
| 31 | Recurrent bacterial skin infections (HP:0005406) | 3.54536438 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.49166667 |
| 33 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.49096459 |
| 34 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.44057351 |
| 35 | Abnormality of complement system (HP:0005339) | 3.43725123 |
| 36 | Conjugated hyperbilirubinemia (HP:0002908) | 3.39122704 |
| 37 | Hypochromic microcytic anemia (HP:0004840) | 3.37303280 |
| 38 | Obstructive lung disease (HP:0006536) | 3.35035530 |
| 39 | Chronic obstructive pulmonary disease (HP:0006510) | 3.35035530 |
| 40 | Petechiae (HP:0000967) | 3.33617509 |
| 41 | Ketoacidosis (HP:0001993) | 3.28728254 |
| 42 | Abnormality of the intrinsic pathway (HP:0010989) | 3.28678516 |
| 43 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.28274987 |
| 44 | Hyperbilirubinemia (HP:0002904) | 3.26288671 |
| 45 | Steatorrhea (HP:0002570) | 3.06244345 |
| 46 | Myocardial infarction (HP:0001658) | 3.04163010 |
| 47 | Abnormality of nucleobase metabolism (HP:0010932) | 2.99591548 |
| 48 | Abnormality of macrophages (HP:0004311) | 2.99098720 |
| 49 | Delayed CNS myelination (HP:0002188) | 2.98658338 |
| 50 | Cellulitis (HP:0100658) | 2.89317149 |
| 51 | Abnormality of serum amino acid levels (HP:0003112) | 2.87762023 |
| 52 | Myositis (HP:0100614) | 2.85902465 |
| 53 | Increased cerebral lipofuscin (HP:0011813) | 2.85138569 |
| 54 | Abnormality of glycolipid metabolism (HP:0010969) | 2.82792966 |
| 55 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.82792966 |
| 56 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.82792966 |
| 57 | Spontaneous abortion (HP:0005268) | 2.82485027 |
| 58 | Increased IgE level (HP:0003212) | 2.79932661 |
| 59 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.79412417 |
| 60 | Dicarboxylic aciduria (HP:0003215) | 2.79412417 |
| 61 | Malnutrition (HP:0004395) | 2.76989607 |
| 62 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.75639245 |
| 63 | Colitis (HP:0002583) | 2.75065712 |
| 64 | Metabolic acidosis (HP:0001942) | 2.74037292 |
| 65 | Lethargy (HP:0001254) | 2.72368037 |
| 66 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.71943180 |
| 67 | Hypertensive crisis (HP:0100735) | 2.71929722 |
| 68 | Purpura (HP:0000979) | 2.71462424 |
| 69 | Increased serum ferritin (HP:0003281) | 2.71017445 |
| 70 | Abnormality of purine metabolism (HP:0004352) | 2.68089629 |
| 71 | Hepatocellular carcinoma (HP:0001402) | 2.64071634 |
| 72 | Gastrointestinal inflammation (HP:0004386) | 2.59093820 |
| 73 | Meningitis (HP:0001287) | 2.52886158 |
| 74 | Acanthocytosis (HP:0001927) | 2.49781835 |
| 75 | Vascular calcification (HP:0004934) | 2.49475601 |
| 76 | Recurrent skin infections (HP:0001581) | 2.48507880 |
| 77 | Epistaxis (HP:0000421) | 2.47798413 |
| 78 | Gout (HP:0001997) | 2.44362405 |
| 79 | Polygenic inheritance (HP:0010982) | 2.42639921 |
| 80 | Recurrent fungal infections (HP:0002841) | 2.41938754 |
| 81 | Inflammation of the large intestine (HP:0002037) | 2.41367524 |
| 82 | Prolonged bleeding time (HP:0003010) | 2.40234278 |
| 83 | Mediastinal lymphadenopathy (HP:0100721) | 2.39979086 |
| 84 | Late onset (HP:0003584) | 2.39236630 |
| 85 | Irritability (HP:0000737) | 2.38977691 |
| 86 | Hepatosplenomegaly (HP:0001433) | 2.38637494 |
| 87 | Systemic lupus erythematosus (HP:0002725) | 2.38033246 |
| 88 | Spastic diplegia (HP:0001264) | 2.36491854 |
| 89 | Ragged-red muscle fibers (HP:0003200) | 2.35588565 |
| 90 | Esophageal varix (HP:0002040) | 2.34403122 |
| 91 | Abnormality of proline metabolism (HP:0010907) | 2.34030993 |
| 92 | Hydroxyprolinuria (HP:0003080) | 2.34030993 |
| 93 | Dysostosis multiplex (HP:0000943) | 2.31260644 |
| 94 | Gingivitis (HP:0000230) | 2.30557102 |
| 95 | Hypertriglyceridemia (HP:0002155) | 2.29168916 |
| 96 | Cerebral edema (HP:0002181) | 2.28526698 |
| 97 | Skin nodule (HP:0200036) | 2.28481817 |
| 98 | Hypoglycemic seizures (HP:0002173) | 2.27793491 |
| 99 | Urticaria (HP:0001025) | 2.24784488 |
| 100 | Thin bony cortex (HP:0002753) | 2.22767934 |
| 101 | Opisthotonus (HP:0002179) | 2.21953815 |
| 102 | Alopecia of scalp (HP:0002293) | 2.21771511 |
| 103 | Cerebral palsy (HP:0100021) | 2.20920696 |
| 104 | Seborrheic dermatitis (HP:0001051) | 2.20332974 |
| 105 | Orchitis (HP:0100796) | 2.19811017 |
| 106 | Gastrointestinal infarctions (HP:0005244) | 2.19213732 |
| 107 | Abnormal gallbladder morphology (HP:0012437) | 2.19203598 |
| 108 | Cardiovascular calcification (HP:0011915) | 2.18923269 |
| 109 | Axonal loss (HP:0003447) | 2.18047801 |
| 110 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.17732687 |
| 111 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.17732687 |
| 112 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.17732687 |
| 113 | Cholelithiasis (HP:0001081) | 2.17711936 |
| 114 | Recurrent viral infections (HP:0004429) | 2.17579256 |
| 115 | Polycythemia (HP:0001901) | 2.17160408 |
| 116 | Pancreatitis (HP:0001733) | 2.16653409 |
| 117 | Generalized aminoaciduria (HP:0002909) | 2.16181656 |
| 118 | Loss of speech (HP:0002371) | 2.15680240 |
| 119 | Vomiting (HP:0002013) | 2.15666173 |
| 120 | Neonatal onset (HP:0003623) | 2.15028792 |
| 121 | Agammaglobulinemia (HP:0004432) | 2.13582004 |
| 122 | Poikilocytosis (HP:0004447) | 2.11950523 |
| 123 | Chest pain (HP:0100749) | 2.09778162 |
| 124 | Amyloidosis (HP:0011034) | 2.09488286 |
| 125 | Turricephaly (HP:0000262) | 2.09350028 |
| 126 | Sensorimotor neuropathy (HP:0007141) | 2.09167963 |
| 127 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.09066671 |
| 128 | Villous atrophy (HP:0011473) | 2.09066671 |
| 129 | Abnormal cartilage morphology (HP:0002763) | 2.08961563 |
| 130 | Thrombocytosis (HP:0001894) | 2.08625423 |
| 131 | Menorrhagia (HP:0000132) | 2.07091726 |
| 132 | Glomerulonephritis (HP:0000099) | 2.03868344 |
| 133 | Gingival bleeding (HP:0000225) | 2.03640265 |
| 134 | Cholecystitis (HP:0001082) | 2.01135864 |
| 135 | Abnormal gallbladder physiology (HP:0012438) | 2.01135864 |
| 136 | Gastrointestinal dysmotility (HP:0002579) | 1.99552047 |
| 137 | Abnormality of the nasal mucosa (HP:0000433) | 1.99190997 |
| 138 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.98195673 |
| 139 | Brushfield spots (HP:0001088) | 1.97260910 |
| 140 | Recurrent cutaneous fungal infections (HP:0011370) | 1.96893387 |
| 141 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.96893387 |
| 142 | Skin rash (HP:0000988) | 1.96531818 |
| 143 | Myopathic facies (HP:0002058) | 1.95372283 |
| 144 | Mucopolysacchariduria (HP:0008155) | 1.95088257 |
| 145 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.95088257 |
| 146 | Bulbar palsy (HP:0001283) | 1.94958544 |
| 147 | Rickets (HP:0002748) | 1.94682882 |
| 148 | Panhypogammaglobulinemia (HP:0003139) | 1.94339960 |
| 149 | Acute hepatic failure (HP:0006554) | 1.94281403 |
| 150 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.93378693 |
| 151 | Ileus (HP:0002595) | 1.91390711 |
| 152 | Alkalosis (HP:0001948) | 1.90568257 |
| 153 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.90543839 |
| 154 | Thrombophlebitis (HP:0004418) | 1.89047771 |
| 155 | Mitral stenosis (HP:0001718) | 1.88884904 |
| 156 | Enlarged kidneys (HP:0000105) | 1.88671222 |
| 157 | Easy fatigability (HP:0003388) | 1.88599175 |
| 158 | Pustule (HP:0200039) | 1.88262098 |
| 159 | Abnormality of iron homeostasis (HP:0011031) | 1.86528809 |
| 160 | Vasculitis (HP:0002633) | 1.85326444 |
| 161 | Nasal polyposis (HP:0100582) | 1.85158541 |
| 162 | Increased muscle lipid content (HP:0009058) | 1.83946223 |
| 163 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.83829418 |
| 164 | Hemorrhage of the eye (HP:0011885) | 1.83201052 |
| 165 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.82523293 |
| 166 | Distal lower limb muscle weakness (HP:0009053) | 1.81982425 |
| 167 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.81619882 |
| 168 | Distal lower limb amyotrophy (HP:0008944) | 1.81421439 |
| 169 | Abnormality of the gallbladder (HP:0005264) | 1.80866648 |
| 170 | Abnormality of urine glucose concentration (HP:0011016) | 1.80308722 |
| 171 | Glycosuria (HP:0003076) | 1.80308722 |
| 172 | Broad face (HP:0000283) | 1.78173179 |
| 173 | Encephalitis (HP:0002383) | 1.76546374 |
| 174 | Proximal tubulopathy (HP:0000114) | 1.75618561 |
| 175 | Growth hormone excess (HP:0000845) | 1.75222262 |
| 176 | Skin ulcer (HP:0200042) | 1.75093992 |
| 177 | Vacuolated lymphocytes (HP:0001922) | 1.74866341 |
| 178 | Reticulocytosis (HP:0001923) | 1.74550935 |
| 179 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.74330165 |
| 180 | Abnormal blistering of the skin (HP:0008066) | 1.74199090 |
| 181 | Prolonged neonatal jaundice (HP:0006579) | 1.71286249 |
| 182 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.70263429 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.70411213 |
| 2 | TAOK3 | 4.35237339 |
| 3 | ERN1 | 3.68130257 |
| 4 | MAPK15 | 3.58038590 |
| 5 | SIK1 | 3.46857414 |
| 6 | ICK | 3.43912279 |
| 7 | SMG1 | 3.26559065 |
| 8 | FGFR4 | 3.19493746 |
| 9 | TESK2 | 2.78410969 |
| 10 | NME2 | 2.55032232 |
| 11 | PINK1 | 2.47104351 |
| 12 | MAP3K11 | 2.38141863 |
| 13 | RIPK4 | 2.36863568 |
| 14 | PRPF4B | 2.34574517 |
| 15 | MAP3K6 | 2.29822134 |
| 16 | DDR2 | 2.13455069 |
| 17 | MAPK11 | 2.07178983 |
| 18 | TRIB3 | 1.87500938 |
| 19 | MST1R | 1.81358337 |
| 20 | ERBB4 | 1.78163185 |
| 21 | IRAK4 | 1.72360709 |
| 22 | FLT3 | 1.64373471 |
| 23 | DYRK1B | 1.58758305 |
| 24 | TNK2 | 1.55205557 |
| 25 | CSK | 1.54920818 |
| 26 | MATK | 1.54480309 |
| 27 | INSRR | 1.49002261 |
| 28 | BLK | 1.48686126 |
| 29 | MAP3K1 | 1.48651155 |
| 30 | ZAP70 | 1.42391591 |
| 31 | PKN2 | 1.40711642 |
| 32 | FES | 1.35088524 |
| 33 | CDK6 | 1.30544206 |
| 34 | VRK2 | 1.28376216 |
| 35 | GRK6 | 1.26844709 |
| 36 | BMX | 1.19809012 |
| 37 | PTK6 | 1.18751493 |
| 38 | LATS1 | 1.15261961 |
| 39 | PRKAA2 | 1.14324144 |
| 40 | TYK2 | 1.14261679 |
| 41 | TESK1 | 1.13650317 |
| 42 | FGR | 1.11552086 |
| 43 | PDGFRA | 1.08439030 |
| 44 | BTK | 1.07894645 |
| 45 | MAP3K13 | 1.07615913 |
| 46 | MAP3K3 | 1.07539239 |
| 47 | MAP3K10 | 1.05439451 |
| 48 | SCYL2 | 1.05416015 |
| 49 | CSF1R | 1.03123562 |
| 50 | RIPK1 | 0.99604111 |
| 51 | EPHB2 | 0.99159355 |
| 52 | IRAK2 | 0.99077415 |
| 53 | JAK3 | 0.98580215 |
| 54 | GSK3A | 0.98506441 |
| 55 | PIM2 | 0.97650770 |
| 56 | PIK3CG | 0.96818641 |
| 57 | TBK1 | 0.96473135 |
| 58 | KDR | 0.96416711 |
| 59 | PRKD2 | 0.94154336 |
| 60 | DAPK1 | 0.93275896 |
| 61 | MAP2K3 | 0.91466994 |
| 62 | JAK2 | 0.90081417 |
| 63 | MAP2K2 | 0.88736099 |
| 64 | IKBKB | 0.88387343 |
| 65 | TIE1 | 0.87420148 |
| 66 | MAP3K7 | 0.87149839 |
| 67 | AKT3 | 0.87013460 |
| 68 | FRK | 0.85950548 |
| 69 | TYRO3 | 0.85073885 |
| 70 | KIT | 0.83529573 |
| 71 | MAPK4 | 0.82649961 |
| 72 | ABL2 | 0.81685103 |
| 73 | PRKAA1 | 0.81240712 |
| 74 | MAP2K6 | 0.80771770 |
| 75 | EEF2K | 0.80388034 |
| 76 | SYK | 0.78110567 |
| 77 | EPHA2 | 0.77007794 |
| 78 | STK38L | 0.76357558 |
| 79 | MAP2K4 | 0.75724195 |
| 80 | TLK1 | 0.75073672 |
| 81 | MAP3K8 | 0.74821870 |
| 82 | TAOK2 | 0.73877005 |
| 83 | PAK4 | 0.71221803 |
| 84 | PIM1 | 0.69770303 |
| 85 | HIPK2 | 0.69692341 |
| 86 | ERBB2 | 0.69115808 |
| 87 | PTK2 | 0.68066603 |
| 88 | CAMK2G | 0.67641705 |
| 89 | ARAF | 0.66942139 |
| 90 | NEK9 | 0.64380112 |
| 91 | HCK | 0.63546418 |
| 92 | CDC42BPA | 0.61958619 |
| 93 | MET | 0.61623007 |
| 94 | PRKCZ | 0.60247602 |
| 95 | PRKACG | 0.59506454 |
| 96 | LATS2 | 0.57590026 |
| 97 | LRRK2 | 0.57218696 |
| 98 | CDK7 | 0.55999739 |
| 99 | LMTK2 | 0.53437633 |
| 100 | MTOR | 0.52938115 |
| 101 | DAPK2 | 0.52298411 |
| 102 | MAPK12 | 0.52173558 |
| 103 | MAPKAPK3 | 0.51485609 |
| 104 | IRAK1 | 0.51238169 |
| 105 | MARK2 | 0.50247154 |
| 106 | EPHB1 | 0.48406699 |
| 107 | RPS6KL1 | 0.47727981 |
| 108 | RPS6KC1 | 0.47727981 |
| 109 | PDK1 | 0.47618680 |
| 110 | LCK | 0.47321874 |
| 111 | PRKG2 | 0.46846702 |
| 112 | RPS6KA2 | 0.46443790 |
| 113 | RPS6KA4 | 0.45213123 |
| 114 | ITK | 0.43661539 |
| 115 | RPS6KA6 | 0.43177854 |
| 116 | PHKG2 | 0.42841066 |
| 117 | PHKG1 | 0.42841066 |
| 118 | MAPKAPK2 | 0.41973601 |
| 119 | SIK3 | 0.41897304 |
| 120 | TRPM7 | 0.41360905 |
| 121 | TAOK1 | 0.41044304 |
| 122 | PRKD3 | 0.39758895 |
| 123 | TGFBR2 | 0.38295116 |
| 124 | TTN | 0.38143755 |
| 125 | IRAK3 | 0.37999456 |
| 126 | EGFR | 0.37559161 |
| 127 | RPS6KA1 | 0.37543626 |
| 128 | STK4 | 0.33051186 |
| 129 | CDK4 | 0.32826559 |
| 130 | JAK1 | 0.32656274 |
| 131 | MAP3K14 | 0.32589255 |
| 132 | MAPK3 | 0.32240030 |
| 133 | MAP2K1 | 0.31898880 |
| 134 | IKBKE | 0.30278359 |
| 135 | RPS6KB2 | 0.29535389 |
| 136 | PDPK1 | 0.29424107 |
| 137 | PIK3CA | 0.28416330 |
| 138 | YES1 | 0.26580845 |
| 139 | LYN | 0.24116693 |
| 140 | PDK2 | 0.23776399 |
| 141 | MAP4K1 | 0.23652295 |
| 142 | FGFR2 | 0.22512741 |
| 143 | PDK3 | 0.22490358 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.13821651 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 3.49709873 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.34847123 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.25483295 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.01346425 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.97208935 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.59040527 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.59011562 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.55462313 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.48197361 |
| 11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.46479127 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.44822415 |
| 13 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.43032747 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.40436964 |
| 15 | Leishmaniasis_Homo sapiens_hsa05140 | 2.16929906 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.13624884 |
| 17 | Allograft rejection_Homo sapiens_hsa05330 | 2.10494178 |
| 18 | Asthma_Homo sapiens_hsa05310 | 2.04498190 |
| 19 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.03960542 |
| 20 | Peroxisome_Homo sapiens_hsa04146 | 2.01144355 |
| 21 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.01043695 |
| 22 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.93354390 |
| 23 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.92312308 |
| 24 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.91485946 |
| 25 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.88655748 |
| 26 | Histidine metabolism_Homo sapiens_hsa00340 | 1.87093829 |
| 27 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.82685348 |
| 28 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.81254480 |
| 29 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.79122197 |
| 30 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.78902295 |
| 31 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.74426426 |
| 32 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.71162588 |
| 33 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.70080568 |
| 34 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.68115220 |
| 35 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.65437694 |
| 36 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.62917207 |
| 37 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.61316724 |
| 38 | Retinol metabolism_Homo sapiens_hsa00830 | 1.60717744 |
| 39 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.55628527 |
| 40 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.53914707 |
| 41 | Bile secretion_Homo sapiens_hsa04976 | 1.52045587 |
| 42 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.50114763 |
| 43 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.49138444 |
| 44 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.48977605 |
| 45 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.45083383 |
| 46 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.44614720 |
| 47 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.41951883 |
| 48 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.37991544 |
| 49 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.36965143 |
| 50 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.35714204 |
| 51 | Sulfur relay system_Homo sapiens_hsa04122 | 1.34816828 |
| 52 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.32197082 |
| 53 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.31754280 |
| 54 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.29990205 |
| 55 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.27988027 |
| 56 | Tuberculosis_Homo sapiens_hsa05152 | 1.27833353 |
| 57 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.26379119 |
| 58 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.26212064 |
| 59 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.23394508 |
| 60 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.23087119 |
| 61 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.21919301 |
| 62 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.19846114 |
| 63 | Carbon metabolism_Homo sapiens_hsa01200 | 1.19288227 |
| 64 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.18019703 |
| 65 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.17314133 |
| 66 | ABC transporters_Homo sapiens_hsa02010 | 1.16647328 |
| 67 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.16439209 |
| 68 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.15489822 |
| 69 | Lysosome_Homo sapiens_hsa04142 | 1.14820694 |
| 70 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.13786826 |
| 71 | Viral myocarditis_Homo sapiens_hsa05416 | 1.12885270 |
| 72 | Pertussis_Homo sapiens_hsa05133 | 1.11679650 |
| 73 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.08294684 |
| 74 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.07678106 |
| 75 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.06559898 |
| 76 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.05066269 |
| 77 | Influenza A_Homo sapiens_hsa05164 | 1.03175746 |
| 78 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.02247474 |
| 79 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.01483864 |
| 80 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.01334656 |
| 81 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.99060153 |
| 82 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.94494485 |
| 83 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.88130080 |
| 84 | Base excision repair_Homo sapiens_hsa03410 | 0.87208781 |
| 85 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.85800174 |
| 86 | Lysine degradation_Homo sapiens_hsa00310 | 0.84236371 |
| 87 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.78653908 |
| 88 | Salmonella infection_Homo sapiens_hsa05132 | 0.77419833 |
| 89 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.76796205 |
| 90 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.75616535 |
| 91 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.75063689 |
| 92 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.74594203 |
| 93 | * Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.73227777 |
| 94 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.70871727 |
| 95 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.70622967 |
| 96 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.66932450 |
| 97 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.66188244 |
| 98 | Shigellosis_Homo sapiens_hsa05131 | 0.65797443 |
| 99 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.65149976 |
| 100 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.62760970 |
| 101 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.62673451 |
| 102 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.61899028 |
| 103 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.61732123 |
| 104 | Malaria_Homo sapiens_hsa05144 | 0.61722839 |
| 105 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.61582597 |
| 106 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.61171086 |
| 107 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.59488436 |
| 108 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.59391923 |
| 109 | Galactose metabolism_Homo sapiens_hsa00052 | 0.58921363 |
| 110 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.57276493 |
| 111 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.57191099 |
| 112 | Phagosome_Homo sapiens_hsa04145 | 0.55992813 |
| 113 | Apoptosis_Homo sapiens_hsa04210 | 0.55501032 |
| 114 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.52803517 |
| 115 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.52422160 |
| 116 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.51745778 |
| 117 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.50679164 |
| 118 | Platelet activation_Homo sapiens_hsa04611 | 0.49989431 |
| 119 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.47306465 |
| 120 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.45069327 |
| 121 | Legionellosis_Homo sapiens_hsa05134 | 0.43742819 |
| 122 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.43231037 |
| 123 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.39736702 |
| 124 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.32366339 |
| 125 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.30754725 |
| 126 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21308721 |
| 127 | Prion diseases_Homo sapiens_hsa05020 | 0.20044247 |
| 128 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.18804304 |
| 129 | Insulin resistance_Homo sapiens_hsa04931 | 0.18569848 |
| 130 | Mineral absorption_Homo sapiens_hsa04978 | 0.08201025 |
| 131 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.06789885 |
| 132 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.06083225 |
| 133 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.05482199 |
| 134 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.04059328 |
| 135 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.03309151 |
| 136 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.00320280 |
| 137 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2397640 |
| 138 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | -0.2354433 |
| 139 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.2234486 |
| 140 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.2059430 |
| 141 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1910280 |
| 142 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1758030 |
| 143 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1705742 |
| 144 | Hepatitis C_Homo sapiens_hsa05160 | -0.1645554 |
| 145 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1470122 |
| 146 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.1157047 |
| 147 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1070134 |
| 148 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0598874 |
| 149 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0581872 |
| 150 | Circadian rhythm_Homo sapiens_hsa04710 | -0.0546858 |
| 151 | Bladder cancer_Homo sapiens_hsa05219 | -0.0221782 |
| 152 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0062855 |

